Who
Grace Colon
Director
Company insider
Files Form 4 as: Director, Voyager Therapeutics; Director, CareDx.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $230K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Jul 2019
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 16 Jun 2023filed 21 Jun 2023 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —29,136 at $0.00 | filing |
| 16 Jun 2023filed 21 Jun 2023 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —18,844 at $0.00 | filing |
| 6 Jun 2023filed 7 Jun 2023 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 1 Jan 2023filed 4 Jan 2023 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Aug 2022filed 11 Aug 2022 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $63K2,521 at $24.81 | filing |
| 16 Jun 2022filed 21 Jun 2022 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,606 at $0.00 | filing |
| 16 Jun 2022filed 21 Jun 2022 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —4,863 at $0.00 | filing |
| 11 May 2022filed 13 May 2022 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $119K5,179 at $23.01 | filing |
| 9 Mar 2022filed 11 Mar 2022 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $48K1,393 at $34.56 | filing |
| 16 Jun 2021filed 21 Jun 2021 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —1,127 at $0.00 | filing |
| 16 Jun 2021filed 21 Jun 2021 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,812 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $156K4,978 at $31.35 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —3,190 at $0.00 | filing |
| 2 Jan 2020filed 3 Jan 2020 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —326 at $0.00 | filing |
| 1 Oct 2019filed 2 Oct 2019 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —270 at $0.00 | filing |
| 1 Jul 2019filed 3 Jul 2019 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,569 at $0.00 | filing |
News
CareDx (NASDAQ:CDNA) vs. Exicure (NASDAQ:XCUR) Head-To-Head ComparisonCDNA · dailypolitical.com · 20 Oct 2026Analyzing CollPlant Biotechnologies (NASDAQ:CLGN) and CareDx (NASDAQ:CDNA)CDNA · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Grace Colon; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.